Janice Wing-Hang Tsang, MBBS, MRCP, FRCP, University of Hong Kong, Hong Kong, China, discusses the key highlights from the 2024 European Society for Medical Oncology (ESMO) Breast meeting, focusing on a comprehensive session about the toxicities of new cancer treatments, including immunotherapy, antibody-drug conjugates (ADCs), and molecular oral agents. The session emphasized proactive patient education and special attention to older adults. This interview took place at the 2024 ESMO Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть